Successful Long-Term Guselkumab Treatment of Severe Plaque Psoriasis in Patients with Class III Obesity: A Case Series
Skin Health and Disease · 01.02.2024 · 4 (1)
DOI: 10.1002/ski2.289 ↗Kurz gefasst
Fallbericht in der Zeitschrift Skin Health and Disease, online erschienen am 19.09.2023. Verfasst von Marco Galluzzo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Systems Medicine University of Rome "Tor Vergata" Rome Italy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This article received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.
Abstract (Originalsprache)
Data from real-world studies and clinical trials have documented the long-term efficacy and safety of guselkumab in patients with moderate-to-severe psoriasis. Limited data are available on the long-term use of guselkumab in morbidly obese individuals with severe psoriasis. Here, we present data on the outcome of three patients with class III obesity (body mass index (BMI) of ≥40 kg/m2) with severe plaque psoriasis treated with 100 mg guselkumab. At baseline, mean BMI was 46.5 ± 5.4 kg/m2 and mean PASI was 46.0 ± 18.5 and all patients were biologic naïve. After 12 weeks of guselkumab treatment, mean PASI decreased to 9.7 ± 4 and to 4.0 ± 1.7 at 28 weeks. After 1 year, two patients achieved complete remission and one patient had PASI of 6 (achieving remission by week 140). All three patients are still in complete remission. Our real-life results in specific patients burdened with class III obesity naïve to biologic treatment show excellent long-term psoriasis outcome with guselkumab.
Autor:innen und Institutionen
- Department of Systems Medicine University of Rome "Tor Vergata" Rome Italy.
- Dermatology Unit Fondazione Policlinico "Tor Vergata" Rome Italy.
Förderung
- This article received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors
Zitieren
APA
Galluzzo, M., Marcelli, L., Fico, A., Bianchi, L., & Talamonti, M. (2024). Successful Long-Term Guselkumab Treatment of Severe Plaque Psoriasis in Patients with Class III Obesity: A Case Series. Skin Health and Disease, 4(1). https://doi.org/10.1002/ski2.289
Vancouver
Galluzzo M, Marcelli L, Fico A, Bianchi L, Talamonti M. Successful Long-Term Guselkumab Treatment of Severe Plaque Psoriasis in Patients with Class III Obesity: A Case Series. Skin Health and Disease. 2024;4(1). doi:10.1002/ski2.289
BibTeX
@article{Galluzzo2024,
author = {Galluzzo, Marco and Marcelli, Lorenzo and Fico, Angela and Bianchi, Luca and Talamonti, Marina},
title = {Successful Long-Term Guselkumab Treatment of Severe Plaque Psoriasis in Patients with Class III Obesity: A Case Series},
journal = {Skin Health and Disease},
year = {2024},
volume = {4},
number = {1},
doi = {10.1002/ski2.289}
}
EUVIMED